Related Experiment Video
Updated: Aug 2, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Enhanced Cationic Charge is a Key Factor in Promoting Staphylocidal Activity of α-Melanocyte Stimulating Hormone via
Jyotsna Singh1, Seema Joshi1, Sana Mumtaz1
1Antimicrobial Research Laboratory, School of Environmental Sciences, Jawaharlal Nehru University, New Delhi-110067, India.
Abstract:
The steady rise in antimicrobial resistance poses a severe threat to global public health by hindering treatment of an escalating spectrum of infections. We have previously established the potent activity of α-MSH, a 13 residue antimicrobial peptide, against the opportunistic pathogen Staphylococcus aureus. Here, we sought to determine whether an increase in cationic charge in α-MSH could contribute towards improving its staphylocidal potential by increasing its interaction with anionic bacterial membranes. For this we designed novel α-MSH analogues by replacing polar uncharged residues with lysine and alanine. Similar to α-MSH, the designed peptides preserved turn/random coil conformation in artificial bacterial mimic 1,2-dimyristoyl-sn-glycero-3-phosphocholine:1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (7:3, w/w) vesicles and showed preferential insertion in the hydrophobic core of anionic membranes. Increased cationic charge resulted in considerable augmentation of antibacterial potency against MSSA and MRSA. With ~18-fold better binding than α-MSH to bacterial mimic vesicles, the most charged peptide KKK-MSH showed enhanced membrane permeabilization and depolarization activity against intact S. aureus. Scanning electron microscopy confirmed a membrane disruptive mode of action for KKK-MSH. Overall, increasing the cationic charge improved the staphylocidal activity of α-MSH without compromising its cell selectivity. The present study would help in designing more effective α-MSH-based peptides to combat clinically relevant staphylococcal infections.
Insights
Increasing the positive charge of the antimicrobial peptide alpha-melanocyte-stimulating hormone (α-MSH) significantly enhanced its ability to kill Staphylococcus aureus, including drug-resistant strains like MRSA.
Area of Science:
- Microbiology
- Biochemistry
- Peptide Science
Background:
- Antimicrobial resistance is a major global health threat.
- Staphylococcus aureus (S. aureus) is an opportunistic pathogen with increasing resistance.
- Alpha-melanocyte-stimulating hormone (α-MSH) shows antimicrobial activity against S. aureus.
Purpose of the Study:
- To investigate if increasing the cationic charge of α-MSH enhances its antibacterial potential.
- To design and evaluate novel α-MSH analogues with modified charge.
Main Methods:
- Designed novel α-MSH analogues by substituting polar residues with lysine and alanine.
- Assessed peptide conformation and membrane interaction using model vesicles.
- Determined antibacterial potency against methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA).
- Evaluated membrane permeabilization, depolarization, and visualized bacterial damage via electron microscopy.
Main Results:
- Novel analogues maintained α-MSH's conformation and membrane interaction properties.
- Increased cationic charge significantly boosted antibacterial potency against MSSA and MRSA.
- The most charged analogue, KKK-MSH, exhibited 18-fold greater binding to bacterial mimics.
- KKK-MSH demonstrated enhanced membrane permeabilization and depolarization, leading to bacterial membrane disruption.
Conclusions:
- Increasing the cationic charge of α-MSH improves its staphylocidal activity and membrane-disrupting capability.
- Enhanced peptides show potent activity against S. aureus without compromising cell selectivity.
- This study provides a foundation for developing improved α-MSH-based therapeutics against staphylococcal infections.
More Related Videos
Related Concept Videos
Micelles
Bioavailability Enhancement: Drug Permeability Enhancement
Antifungal Agents

